Thrombotic Complications Associated with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Patients with cancer commonly develop blood clots, which can cause issues including hospitalizations and complications and can affect cancer treatments. Cancer therapies can be one of the reasons for blood clots. A type of cancer therapy called “immune checkpoint inhibitors” has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tzu-Fei, Khorana, Alok A., Carrier, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469452/
https://www.ncbi.nlm.nih.gov/pubmed/34572833
http://dx.doi.org/10.3390/cancers13184606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469452/
https://www.ncbi.nlm.nih.gov/pubmed/34572833
http://dx.doi.org/10.3390/cancers13184606

Ejemplares similares